If p53 can't do it, ask p73

被引：0

作者：

Lain, Sonia ^{[1
,2
]}

机构：

[1] Univ Dundee, Ninewells Hosp, Dept Surg & Mol Oncol, Dundee, Scotland

[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden

来源：

CELL CYCLE | 2008年 / 7卷 / 21期

关键词：

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：3290 / 3291

页数：2

共 12 条

[1] Targeted rescue of a destabilized mutant of p53 by an in silico screened drug [J].

Boeckler, Frank M. ;

Joerger, Andreas C. ;

Jaggi, Gaurav ;

Rutherford, Trevor J. ;

Veprintsev, Dmitry B. ;

Fersht, Alan R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (30) :10360-10365

[2] Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy [J].

Bossi, Gianluca ;

Marampon, Francesco ;

Maor-Aloni, Revital ;

Zani, Bianca ;

Rotter, Varda ;

Oren, Moshe ;

Strano, Sabrina ;

Blandino, Giovanni ;

Sacchi, Ada .

CELL CYCLE, 2008, 7 (12) :1870-1879

[3] Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].

Bottger, A ;

Bottger, V ;

Sparks, A ;

Liu, WL ;

Howard, SF ;

Lane, DP .

CURRENT BIOLOGY, 1997, 7 (11) :860-869

[4] A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain [J].

Gaiddon, C ;

Lokshin, M ;

Ahn, J ;

Zhang, T ;

Prives, C .

MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1874-1887

[5] Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors [J].

Issaeva, N ;

Bozko, P ;

Enge, M ;

Protopopova, M ;

Verhoef, LGGC ;

Masucci, M ;

Pramanik, A ;

Selivanova, G .

NATURE MEDICINE, 2004, 10 (12) :1321-1328

[6] Structural basis for understanding oncogenic p53 mutations and designing rescue drugs [J].

Joerger, Andreas C. ;

Ang, Hwee Ching ;

Fersht, Alan R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (41) :15056-15061

[7] Reactivation of mutant p53: molecular mechanisms and therapeutic potential [J].

Selivanova, G. ;

Wiman, K. G. .

ONCOGENE, 2007, 26 (15) :2243-2254

[8] Targeting the MDM2-p53 interaction for cancer therapy [J].

Shangary, Sanjeev ;

Wang, Shaomeng .

CLINICAL CANCER RESEARCH, 2008, 14 (17) :5318-5324

[9] Physical and functional interaction between p53 mutants and different isoforms of p73 [J].

Strano, S ;

Munarriz, E ;

Rossi, M ;

Cristofanelli, B ;

Shaul, Y ;

Castagnoli, L ;

Levine, AJ ;

Sacchi, A ;

Cesareni, G ;

Oren, M ;

Blandino, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29503-29512

[10] In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 [J].

Vassilev, LT ;

Vu, BT ;

Graves, B ;

Carvajal, D ;

Podlaski, F ;

Filipovic, Z ;

Kong, N ;

Kammlott, U ;

Lukacs, C ;

Klein, C ;

Fotouhi, N ;

Liu, EA .

SCIENCE, 2004, 303 (5659) :844-848

← 1 2 →